NEVVI Medicare utilization intelligence

← back

NJUGUNA, NDEGWAM.D. NPI 1851577522 Clinician

Hematology-Oncology · TACOMA, WA

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 25 years since medical school (class of 2001, self-reported to CMS)
Location TACOMA, WA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 78 codes billed · 151,489 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
NORTHWEST MEDICAL SPECIALTIES PLLC
2019–2026
CANCER CARE NORTHWEST CENTERS PS
2019

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-09

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9267 Injection, paclitaxel, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J2405 Injection, ondansetron hydrochloride, per 1 mg
36415 Insertion of needle into vein for collection of blood sample
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J0640 Injection, leucovorin calcium, per 50 mg
J9190 Injection, fluorouracil, 500 mg
80053 Blood test, comprehensive group of blood chemicals
J9045 Injection, carboplatin, 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
88185 Flow cytometry technique for dna or cell analysis, each additional marker
96415 Administration of chemotherapy into vein, each additional hour
96372 Injection of drug or substance under skin or into muscle
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
82784 Gammaglobulin (immune system protein) measurement
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
83615 Lactate dehydrogenase (enzyme) level
82728 Ferritin (blood protein) level
83540 Iron level
84466 Transferrin (iron binding protein) level
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96417 Administration of additional new drug or substance into vein, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
82607 Cyanocobalamin (vitamin b-12) level
82248 Bilirubin level, direct
82977 Glutamyltransferase (liver enzyme) level
96360 Infusion into a vein for hydration, 31-60 minutes
J7030 Infusion, normal saline solution , 1000 cc
84439 Thyroxine (thyroid chemical), free
82533 Cortisol (hormone) measurement, total
J3475 Injection, magnesium sulfate, per 500 mg
82746 Folic acid level, serum
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
84443 Blood test, thyroid stimulating hormone (tsh)
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96374 Injection of drug or substance into vein
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96361 Infusion into a vein for hydration, each additional hour
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
J3490 Unclassified drugs
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
84153 Psa (prostate specific antigen) measurement, total
96411 Administration of additional new drug or substance into vein using push technique
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
85046 Red blood count automated, with additional calculations
36591 Collection of blood sample from implanted device
86706 Hepatitis b surface antibody measurement
86803 Hepatitis c antibody measurement
87340 Detection test by immunoassay technique for hepatitis b surface antigen
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
86704 Hepatitis b core antibody measurement
86708 Measurement of hepatitis a antibody
99195 Drawing of blood for a medical problem
83735 Magnesium level
85652 Red blood cell sedimentation rate, to detect inflammation, automated
84550 Uric acid level, blood
82378 Carcinoembryonic antigen (cea) protein level
88184 Flow cytometry technique for dna or cell analysis, first marker
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.